Barb Kunz, MS, LCGC, senior genetic counselor at the US Oncology Network, discussed the importance of germline genetic testing in patients with triple-negative breast cancer and other cancer types.
Barb Kunz, MS, LCGC, senior genetic counselor at the US Oncology Network, discussed the importance of germline genetic testing in patients with triple-negative breast cancer and other cancer types.
In a study presented at the 2023 American Society of Clinical Oncology Annual Meeting, Kunz and colleagues found that social determinants of health, particularly related to race and the type of insurance coverage patients had, impacted genetic testing rates in the community oncology setting.
Transcript
What are the implications of these findings for patients with TNBC and other cancer types where germline testing is recommended?
I think the biggest implication is trying to understand why these differences exist, and how can we address them? And where along the whole genetic testing workflow these people weren't getting what they needed. Were they not identified in the first place for genetic testing? Were they not referred, were they referred and didn't have an appointment? If they had an appointment, why did they choose not to do testing?
And it's not that everyone should do testing—people have options and real reasons why they don't do testing. But we need to understand why there's that discrepancy and address it. And it will apply to other cancers. Can we do systemic things like change workflows to make sure that people don't overlook these indications for genetic testing? Because the indications for genetic testing are just going to keep increasing, and we need our providers really understand that, and our patients [need to] understand the value of genetic testing.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More